Mindfulness Based Smoking Cessation Among Cancer Survivors
Key facts
- Who runs it
- University of Miami
- Where
- Memphis and Miami, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- Phase
- Phase 4
- People taking part
- 20 people enrolled
- Started
- 28 Sept 2019
- Ended
- 19 May 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nicoderm C-Q Transdermal Product
- Orientation session
- Craving-to-Quit app
- Two brief follow-up phone calls
- Group MT sessions
- Brief advice on quitting smoking
- Self-help smoking cessation materials
- Record updated
- 9 September 2025
- Why it stopped
- Recruitment for the study proved to be a significant challenge, raising important concerns about its overall feasibility.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Be 18 years and older
- Cancer survivors (based on the NCI definition - "a person is considered to be a survivor from the time of diagnosis until the end of life" National Cancer Institute Dictionary of Cancer Terms, 2014)
- Cancer patients currently in active treatment
- Have smoked ≥ 5 cigarettes/day in the past year
- Be interested in making a quit attempt in the next 30 days
- Own a smartphone (apple/android)
- Read/speak English
- Able to consent
- Have no plans to move in the next 3 months
- Are not pregnant or planning to be pregnant in the following 3 months
Who cannot take part
- Are currently being treated for smoking cessation, alcoholism, or illicit drug use
- Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
- Are currently being treated for a psychiatric condition
- Are adults unable to consent
- Are individuals who are not yet adults
- Are pregnant women
- Are prisoners
Where in United States
- St. Jude Children's Research HospitalMemphis, United States
- University of MiamiMiami, United States
About the trial
What the trial wants to find out
This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
The 3 groups in the trial
- Usual CareExisting treatment, for comparison
Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.
Treatment: Nicoderm C-Q Transdermal Product, Brief advice on quitting smoking, and Self-help smoking cessation materials
- Craving-to-Quit appTreatment being tested
Participants in this group will receive one "in-person" or online orientation session, 6-week supply of NRT, the "Craving-to-Quit" app, and two brief follow-up phone calls.
Treatment: Nicoderm C-Q Transdermal Product, Orientation session, Craving-to-Quit app, and Two brief follow-up phone calls
- Group Mindfulness TrainingTreatment being tested
Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with \>4 years of training in MT).
Treatment: Nicoderm C-Q Transdermal Product, Orientation session, and Group MT sessions
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smartphone Application Versus Group Mindfulness-based Smoking Cessation Intervention for Cancer Patients and Survivors: Reach Versus Effectiveness
- Record updated
- 9 September 2025